IP Library Granted Patent US 7,678,103
Granted Patent B2
US 7,678,103 · App. 10/460,460 · Granted Mar 16, 2010

Orifice device for delivering drugs at low fluid flow rates

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,678,103
App. No.
10/460,460
Granted
Mar 16, 2010
Kind
B2
Abstract

An orifice device for delivering a drug includes an inner member having a proximal end and a distal end. A winding is helically wound around the inner member. The winding and the inner member define a first channel for carrying a drug therethrough. An inlet is at the proximal end of the winding and an outlet is at the distal end of the winding.

Claims (31)

1. An orifice device for delivering a drug comprising:

an inner member having a proximal end and a distal end;

a winding helically wound around the inner member, wherein the winding comprises a wire and wherein the wire has a width ranging from 0.001-0.050 inches;

the exterior surface of the winding and the inner member defining a first channel having a helical flowpath following the curvature of the winding for carrying a drug therethrough and an inlet at the proximal end of the winding and an outlet at the distal end of the winding;

a first drug carrying path defined by a first inlet at the proximal end of the winding, the first channel having a helical flowpath following the curvature of the winding, and a first outlet at the distal end of the winding;

an outer member over the winding, wherein the exterior surface of the winding and the outer member define a second channel having a helical flow path following the curvature of the winding for carrying a drug therethrough; and

a second drug carrying path defined by a second inlet at the proximal end of the winding, the second channel having a helical flowpath following the curvature of the winding, and a second outlet at the distal end of the winding, wherein the first and second drug carrying paths are capable of delivering two separate drugs.

2. The orifice device according to claim 1 , wherein the wire has a circular shape in cross-section.

3. The orifice device according to claim 1 , wherein the wire has a hexagonal shape in cross-section.

4. The orifice device according to claim 1 , wherein the wire has an octagonal shape in cross-section.

5. The orifice device according to claim 1 , wherein the wire has a triangular shape in cross-section.

6. The orifice device according to claim 1 , wherein the outer member is a sleeve.

7. The orifice device according to claim 1 , wherein the outer member is made of a polymer material.

8. The orifice device according to claim 7 , wherein the polymer material is PTFE.

9. The orifice device according to claim 1 , wherein the wire is made of a degradation-resistant material.

10. The orifice device according to claim 9 , wherein the material is a nickel titanium alloy.

11. The orifice device according to claim 9 , wherein the material is a stainless steel alloy.

12. The orifice device according to claim 9 , wherein the material is plastic.

13. The orifice device according to claim 1 , wherein the wire has a width ranging from 0.004-0.005 inches.

14. An implantable drug delivery device comprising:

an inner member having a proximal end and a distal end;

a winding helically wound around the inner member, wherein the winding comprises a wire and wherein the wire has a width ranging from 0.001-0.050 inches;

the exterior surface of the winding and the inner member defining a first channel having a helical flowpath following the curvature of the winding for carrying a drug therethrough and an inlet at the proximal end of the winding and an outlet at the distal end of the winding;

a first drug carrying path defined by a first inlet at the proximal end of the winding, the first channel having a helical flowpath following the curvature of the winding, and a first outlet at the distal end of the winding;

an outer member over the winding, wherein the exterior surface of the winding and the outer member define a second channel having a helical flow path following the curvature of the winding for carrying a drug therethrough;

a second drug carrying path defined by a second inlet at the proximal end of the winding, the second channel having a helical flowpath following the curvature of the winding, and a second outlet at the distal end of the winding, wherein the first and second drug carrying paths are capable of delivering two separate drugs; and

a housing.

15. The implantable drug delivery device of claim 14 further comprising a pump device.

16. The implantable drug delivery device of claim 15 wherein the pump device is an osmotically driven ruminal bolus.

17. The implantable drug delivery device of claim 14 wherein the implantable drug delivery device is permanently implanted.

18. The implantable drug delivery device of claim 14 wherein the implantable drug delivery device is made of a biocompatible and bio absorbable material.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 1, 2025
From: CARDINAL HEALTH SWITZERLAND 515 GMBH; CARDINAL HEALTH 529, LLC; CORDIS CORPORATION; FLEXIBLE STENTING SOLUTIONS, INC
To: CORDIS US CORP
Reel/Frame 072987/0675 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 31, 2017
From: CORDIS CORPORATION
To: CARDINAL HEALTH SWITZERLAND 515 GMBH
Reel/Frame 042126/0259 →